{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:43:07Z","timestamp":1792788187747,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca PLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtcvs.2026.04.058","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:33:39Z","timestamp":1788478419000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical outcomes by type of surgery with perioperative durvalumab in patients with resectable non\u2013small cell lung cancer"],"prefix":"10.1016","author":[{"given":"David","family":"Harpole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V.","family":"Heymach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis","family":"Taube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shugeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaofeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinh","family":"Van Luong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somcharoen","family":"Saeteng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Doake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer M.","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Mitsudomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.jtcvs.2026.04.058_bib3","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa2304875","article-title":"Perioperative durvalumab for resectable non-small-cell lung cancer","volume":"389","author":"Heymach","year":"2023","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jtcvs.2026.04.058_bib4","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jtho.2024.09.069","article-title":"OA13.03 perioperative durvalumab for resectable NSCLC (R-NSCLC): updated outcomes from the phase 3 AEGEAN trial","volume":"19","author":"Heymach","year":"2024","journal-title":"J Thorac Oncol"},{"issue":"6","key":"10.1016\/j.jtcvs.2026.04.058_bib5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative pembrolizumab for early-stage non\u2013small-cell lung cancer","volume":"389","author":"Wakelee","year":"2023","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.jtcvs.2026.04.058_bib6","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1056\/NEJMoa2311926","article-title":"Perioperative nivolumab in resectable lung cancer","volume":"390","author":"Cascone","year":"2024","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jtcvs.2026.04.058_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jama.2023.24735","article-title":"Perioperative toripalimab plus chemotherapy for patients with resectable non\u2013small cell lung cancer: the Neotorch randomized clinical trial","volume":"331","author":"Lu","year":"2024","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jtcvs.2026.04.058_bib8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.annonc.2024.01.005","article-title":"VP1-2024: RATIONALE-315: event-free survival (EFS) and overall survival (OS) of neoadjuvant tislelizumab (TIS) plus chemotherapy (CT) with adjuvant TIS in resectable non\u2013small cell lung cancer (NSCLC)","volume":"35","author":"Yue","year":"2024","journal-title":"Ann Oncol"},{"issue":"21","key":"10.1016\/j.jtcvs.2026.04.058_bib9","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2026.04.058_bib10","series-title":"Paper Presented at the 104th Annual Meeting of the American Association for Thoracic Surgery (AATS)","article-title":"Surgical outcomes with perioperative nivolumab in patients with resectable NSCLC from the phase 3 CheckMate 77T study","author":"Kuzdzal","year":"2024"},{"issue":"suppl 16","key":"10.1016\/j.jtcvs.2026.04.058_bib11","doi-asserted-by":"crossref","first-page":"8521","DOI":"10.1200\/JCO.2023.41.16_suppl.8521","article-title":"Clinical outcomes with neoadjuvant nivolumab (N) + chemotherapy (C) vs C by definitive surgery in patients (pts) with resectable NSCLC: 3-y results from the phase 3 CheckMate 816 trial","volume":"41","author":"Spicer","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2026.04.058_bib12","series-title":"Paper Presented at the 60th Annual Meeting of the Society of Thoracic Surgeons (STS)","article-title":"Impact of surgical factors on event-free survival in the randomized, placebo-controlled, phase 3 KEYNOTE-671 trial of perioperative pembrolizumab for early-stage non-small-cell lung cancer","author":"Spicer","year":"2024"},{"issue":"11","key":"10.1016\/j.jtcvs.2026.04.058_bib13","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jtho.2025.06.015","article-title":"Surgical outcomes with neoadjuvant durvalumab plus chemotherapy followed by adjuvant durvalumab in resectable NSCLC","volume":"20","author":"Mitsudomi","year":"2025","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.04.058_bib14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2214\/AJR.21.26408","article-title":"The evolving landscape of lung cancer surgical resection: an update for radiologists with focus on key chest CT findings","volume":"218","author":"Stefanidis","year":"2022","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.jtcvs.2026.04.058_bib15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/ejcts\/ezu028","article-title":"Revised ESTS guidelines for preoperative mediastinal lymph node staging for non\u2013small-cell lung cancer","volume":"45","author":"De Leyn","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"10.1016\/j.jtcvs.2026.04.058_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.04.058_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.lungcan.2005.01.001","article-title":"Complete resection in lung cancer surgery: proposed definition","volume":"49","author":"Rami-Porta","year":"2005","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.jtcvs.2026.04.058_bib18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jtho.2020.01.005","article-title":"IASLC multidisciplinary recommendations for pathologic assessment of lung cancer resection specimens after neoadjuvant therapy","volume":"15","author":"Travis","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"10","key":"10.1016\/j.jtcvs.2026.04.058_bib19","first-page":"1742","article-title":"Bronchial sleeve resection or pneumonectomy for non\u2013small cell lung cancer: a propensity-matched analysis of long-term results, survival and quality of life","volume":"7","author":"Andersson","year":"2015","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jtcvs.2026.04.058_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114233","article-title":"An international registry study of early-stage NSCLC treatment variations (LUCAEUROPE) in Europe and the USA highlighting variations","volume":"209","author":"Baum","year":"2024","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.jtcvs.2026.04.058_bib21","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.21037\/jtd-21-264","article-title":"Evaluation of different treatment strategies between right-sided and left-sided pneumonectomy for stage I-IIIA non\u2013small cell lung cancer patients","volume":"13","author":"Jia","year":"2021","journal-title":"J Thorac Dis"},{"issue":"1","key":"10.1016\/j.jtcvs.2026.04.058_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/02184923231212657","article-title":"An analysis of long-term survival after pneumonectomy for lung cancer: a retrospective study of 20 years","volume":"32","author":"Ravishankar","year":"2024","journal-title":"Asian Cardiovasc Thorac Ann"},{"issue":"9","key":"10.1016\/j.jtcvs.2026.04.058_bib23","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.21037\/tlcr-24-700","article-title":"Effect of laterality on the postoperative survival of non\u2013small cell lung cancer patients undergoing pneumonectomy","volume":"13","author":"Wang","year":"2024","journal-title":"Transl Lung Cancer Res"},{"issue":"11","key":"10.1016\/j.jtcvs.2026.04.058_bib24","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jtho.2025.06.015","article-title":"Surgical outcomes with neoadjuvant durvalumab plus chemotherapy followed by adjuvant durvalumab in resectable NSCLC","volume":"20","author":"Mitsudomi","year":"2025","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10.1016\/j.jtcvs.2026.04.058_bib25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jtho.2020.01.005","article-title":"IASLC multidisciplinary recommendations for pathologic assessment of lung cancer resection specimens after neoadjuvant therapy","volume":"15","author":"Travis","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.jtcvs.2026.04.058_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.jtcvs.2026.04.058_bib27","series-title":"AJCC Cancer Staging Manual","year":"2018"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522326012882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522326012882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:13:56Z","timestamp":1792786436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522326012882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":25,"alternative-id":["S0022522326012882"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2026.04.058","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes by type of surgery with perioperative durvalumab in patients with resectable non\u2013small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2026.04.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Association for Thoracic Surgery.","name":"copyright","label":"Copyright"}]}}